Priligy® - Dapoxetine

Here are some note worthy news pieces showing the
general development of Priligy® / Dapoxetine.
It is not our intention to follow every single news story
that ever mentions this drug, but rather give an indication
of a time line from its early beginnings of what has
happened with Priligy® / Dapoxetine to what is happening
today with its development. Please note these news
pieces are pharaphrased and maybe brief in content in
order to provide a quick overview.




October 26th, 2005
Dapoxetine Denied by the FDA
ALZA Corporation announced today that it has received a "disapprove" letter from the U.S. Food and Drug Administration on their New Drug Application for dapoxetine hydrochloride, a trial drug used to treat premature ejaculation (PE). ALZA however plans to address questions that where raised in the letter they received and still plans on developing this medication for PE.



September 8th, 2006
Dapoxetine Deemed Safe And Effective In Treating Premature Ejaculation
Researchers at the University of Minnesota stated that after research on 2,600 men they deemed that Dapoxetine increased the duration of intercourse from less than a minute to three minutes and 19 seconds.
© 2010
Priligy® / Dapoxetine Information